You are here
Clinical Trials: Cord Blood
Interventions: Drug: Reduced Toxicity Ablative Regimen; Drug: Reduced Intensity Preparative Regimen; Drug: Myeloablative Preparative Regimen
Sponsor: Masonic Cancer Center, University of Minnesota
Interventions: Biological: unrelated BM with T cell depletion; Biological: unrelated cord blood; Biological: haplo BM with T cell depletion; Device: unrelated PBSC with T cell depletion
Sponsor: Neena Kapoor, M.D.
Interventions: Drug: Fludarabine; Procedure: Hematopoietic Stem Cell Transplant (HSCT)
Sponsor: Case Comprehensive Cancer Center
Recruiting - verified July 2017
Interventions: Biological: human umbilical cord blood derived mesenchymal stem cells; Other: Normal saline 2mL
Sponsor: Medipost Co Ltd.
Recruiting - verified April 2017
Intervention: Genetic: Autologous Stem Cells
Sponsors: James Baumgartner, MD; CBR Systems, Inc.
Intervention: Device: Stem Cell Educator
Sponsors: Tianhe Stem Cell Biotechnologies Inc.; Second Xiangya Hospital of Central South University
Intervention: Biological: Stem cells
Sponsor: Kang Stem Biotech Co., Ltd.
Recruiting - verified September 2016
Interventions: Biological: Autologous Stem Cells; Other: Saline Infusion (Placebo)
Sponsors: The University of Texas Health Science Center, Houston; Cord Blood Registry, Inc.; Let's Cure CP Foundation; Mission Connect, a program of TIRR Foundation
Active, not recruiting - verified June 2017
Intervention: Other: Cord Blood Transplantation
Sponsor: Assistance Publique - Hôpitaux de Paris
Interventions: Drug: Hydroxyurea; Drug: Alemtuzumab; Drug: Fludarabine; Drug: Melphalan; Drug: Thiotepa
Sponsor: University of Pittsburgh
Recruiting - verified March 2017